Delayed head and neck cancer diagnosis delays due to increased antibiotic prescribing periods are known to be harmful to patients.
Data Show Trend Toward Increased Use of and Improved Complication Rates for Endoscopic Transsphenoidal Approach to Pituitary Tumors
In recent years, rates of an endoscopic approach to pituitary tumors use have increased. Literature comparing postoperative outcomes of various approaches has been mixed.
Dynamic Risk Stratification Tool Effective in Predicting Postoperative Tall Cell Variant Papillary Thyroid Cancer Course
A Dynamic Risk Stratification tool showed that patients with postoperative tall cell variant papillary thyroid cancer who achieve an excellent overall response to therapy at any point during follow-up have significantly improved outcomes.
Why Wait Until After Surgery? The Case for Pre-habilitation in Head and Neck Cancer Care
Multimodal pre-habilitation and rehabilitation have been an important topics in the literature, aiming to combat modifiable patient factors like sarcopenia, malnutrition, and psychological status.
COSM 2023 Sessions: A Review of Otolaryngology Topics
In April 2023, we listed a variety of topics at the 2023 Combined Otolaryngology Spring Meetings (COSM) in Boston that had piqued the interest of ENTtoday’s physician editor Robin W. Lindsay, MD. This time, we’ve taken a closer look and highlighted some of the topics chosen.
Nutrition Is Vital for Patients with Head and Neck Cancer
The nutritional impact of head and neck cancer (HNC) doesn’t begin with diagnosis: approximately 30% of affected patients are malnourished prior to diagnosis and treatment and need a multidisciplinary care plan that begins before treatment, continues during therapy, and extends well after treatment.
Anaplastic Thyroid Cancer Treatment by Multidisciplinary Palliative, Radiation, Oncology, and Surgical Teams
Resectable stage IVA/IVB tumors should be treated with surgery followed by chemoradiation, with consideration for dabrafenib/trametinib biotherapy for BRAFV600E-mutated tumors.
Novel Machine Learning Predicts Oral Squamous Cell Carcinoma Recurrence Timing
Machine learning methods can interpret complex patterns of patient, clinicopathological, and treatment factors to predict timing of oral squamous cell carcinoma recurrence.
Telehealth Care for HNC Cancer Survivors Compares Favorably to Standard Care in Certain Outcomes
Telehealth survivorship programs are feasible, cost-effective, and associated with improved patient outcomes but are not ideal for every patient.
Nuclear Medical Imaging Is Recommended in the Diagnosis and Management of Head and Neck Paragangliomas
Nuclear medical imaging is strongly recommended in the diagnosis of paragangliomas that are familial, SDHB variants, malignant, or potentially multifocal, but those that have classic presentations do not routinely require peptide receptor imaging.
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 42
- Next Page »